Standing room only at Amyloid Rapid Cases #ASNC2024 Take home messages 🚨SPECT CT helps determine myocardial uptake in equivocal cases 🚨if uncertain- endomyocardial ❤️biopsy remains gold standard 🚨multimodality also helps - if contraindications for MRI, can get ECV with CT

🚀 Elevate your expertise in ATTR-CM at the 3rd International Congress on ATTR Amyloidosis. Join our interactive, 🧠 expert-led session with Mazen Hanna and Brett Sperry, MD. Click here now: ms.spr.ly/6015m8iUt #ICAAlive24

Congrats Dr. Amanda Vest ⁦Dr Amanda Vest⁩ for receiving the George & Linda Kaufman Endowed Chair for Heart Failure; successor to mentor Dr. Jim Young. Proud moment at the Cleveland Clinic. ⁦Samir Kapadia⁩ ⁦Randall Starling⁩ ⁦⁦⁦Lars Svensson⁩

Register and tune in tomorrow from 11 AM to 12 PM EST to review two key clinical trials in ATTR-CM with engaging discussion. Marianna Fontana to review Helios B and Ahmad Masri to review ATTRibute CM. Exciting times for Cardiac Amyloidosis. Ronald Witteles Brett Sperry, MD

Go inside the operating room for open-heart surgery. Dr. Eric Roselli gives us a behind-the-scenes look at a complex procedure.

This is a very important subject, caring for the caregiver of a patient with amyloidosis. Registration link below. Isabelle Lousada Kristen Hsu mathew.maurer Frederick L Ruberg Martha Grogan MD Brett Sperry, MD Ahmad Masri Ronald Witteles Julie Lorraine Rosenthal Justin L. Grodin us02web.zoom.us/webinar/regist…

Dan Judge presenting excellent results from ATTRibute-CM to OLE #CardioTwitter

Excited to see the second ever drug approval for #ATTR cardiomyopathy. Another triumph for science 🧪 and great news for patients. Congratulations to all who have been involved in this journey! #ATTRUBY BridgeBio Pharma Martha Grogan MD Kevin Alexander Kenneth Mahaffey Paul Cheng

🆕 #ESCTVToday containing 2 🔥 expert masterclasses: 1. #Coronary spasm #ANOCA w/ EHJ Editor-in-Chief (+extended interview) 2. Sex differences #HeartFailure w/ Lynne Stevenson And lots more!! (London 🚌 driver trial, anyone?) European Society of Cardiology Full episode here 👇 esc365.escardio.org/event/1797

95% of our patients undergoing valve-sparing aortic root replacement are free from reoperation after 15 years. Learn more: cle.clinic/410l5QA

#UCARS25 just 2 days away! There is still time to register for the complimentary live feed broadcasting: Keynote address by Dr. Bristow & terrific bench-to-bedside agenda: medicine.utah.edu/internal-medic…

Jignesh Patel was humble, kind, and brilliant. Always positive and incredibly resilient. I will miss you my friend. The world is a better place because of you. Rest in peace.

As ❤ month closes, let's not lose sight of recent advances in TTR Amyloid - my thoughts in Journal of Cardiac Failure w/ Paloma Remior on tafamidis in the real world and newer therapies entering the arena. Will the data support tafamidis' 1st mover advantage? sciencedirect.com/science/articl…

We are excited to share our perspective on building a multidisciplinary Amyloidosis program from the ground up. Challenges and ways we overcame them. Thank you American College of Cardiology for the platform to share our story Jefferson Health ColumbiaCardiology acc.org/Latest-in-Card…

A monumental day for the #ATTR #amyloidosis field: #Vutrisiran is now FDA approved for ATTR-CM! The landmark #HELIOS-B trial hit 10/10 prespecified endpoints including improved all-cause mortality. Congratulations to everyone who contributed to the development/approval, and a

And then there were 3! Ronald Witteles Ahmad Masri Martha Grogan MD Mazen Hanna Brett Sperry, MD Kevin Alexander Yevgeniy Brailovsky DO MSc FACC Melissa Lyle Rafael Fonseca MD 🦔🇺🇸🏜🇲🇽 Justin L. Grodin investors.alnylam.com/press-release?…

We presented updated data from 97 patients who underwent I124-evuzamitide PET/MRI imaging. Excellent diagnostic performance. Even when we used LV blood pool the SUVR seperation remains robust. Desc aorta is even more impressive. Some examples. #ACC25 #CardioTwitter ##MEDIQACC25

AMYLOIDOSIS LECTURE SERIES - NEW EPISODE youtube.com/watch?v=mrB_jG… Dr. Ahmad Masri, Director of the Cardiac Amyloidosis Program at Oregon Health & Science University (OHSU), reminds us about the traditional approach to diagnosis of cardiac amyloidosis. Unfortunately, this has not

Please share this exciting and interactive Amyloid case based seminar w/your fellow Amyloid champions and trainees. Brett Sperry, MD Mazen Hanna Melissa Lyle Martha Grogan MD Ahmad Masri Yevgeniy Brailovsky DO MSc FACC Michelle Kittleson MD PhD Ronald Witteles Rafael Fonseca MD 🦔🇺🇸🏜🇲🇽 Kevin Alexander

🫀Should stabilizers + silencers be combined in ATTR-CM? In the latest #DontMissABeat, Ahmad Masri joins hosts Muthu Vaduganathan & Steve Greene to explore emerging therapies, real-world dilemmas, & what’s next in transthyretin amyloid #cardiomyopathy. hcplive.com/view/don-t-mis…